Pharma

Mar 31 2017

URL Pharma may no longer be cash cow in Philadelphia #par #pharma

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Mar 18 2017

URL Pharma may no longer be cash cow in Philadelphia #british #pharmaceutical #companies

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Dec 8 2016

URL Pharma may no longer be cash cow in Philadelphia #ranbaxy

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Nov 12 2016

URL Pharma may no longer be cash cow in Philadelphia #online #pharma

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Oct 27 2016

URL Pharma may no longer be cash cow in Philadelphia #pakistan #pharma #guide

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Oct 5 2016

URL Pharma may no longer be cash cow in Philadelphia #pharma #tutor

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Sep 26 2016

URL Pharma may no longer be cash cow in Philadelphia

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …

Sep 17 2016

URL Pharma may no longer be cash cow in Philadelphia

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …